In light of the challenges seen since President Nixon launched the first "war on cancer" in 1971, experts say any new approach to cures, moonshot or otherwise, must get back to the basics. The oncology community agrees a coordinated approach could address the clinical research challenges.
Clinical pathways, lists meant to guide clinicians toward the optimal course of treatment, have reached the point of being an “unsustainable” administrative burden, according to the American Society of Clinical Oncology, and the process of developing them is laden with inadequacies and...
The American Society of Clinical Oncology says so-called clinical pathways created and distributed by payers and for-profit firms are laden with inadequacies and conflicts of interest.
Pfizer's $160 billion deal to acquire Irish drugmaker Allergan got a lot of attention for the tax advantages Pfizer would enjoy from moving its New Jersey headquarters overseas to Dublin. There wasn't much talk, though, about how much the deal would expand Pfizer's footprint in biosimilars.
Joseph Mallas has been named president and CEO of U.S. HealthWorks, an occupational-health and urgent-care subsidiary of San Francisco-based Dignity Health.
Providers say they don't have the resources to adhere to enforcement of decades-old laws calling for the FDA to police laboratory-developed tests. The CMS rejected requests that it, not the FDA, have oversight of the tests, which are manufactured and performed within a single hospital or in...
Competition is building in the cancer-care field, as hospitals, health systems and physician groups are constructing new cancer centers in response to the aging of the baby boomers and a projected increase in cancer diagnoses over the next 20 years.
The media may inadvertently be the biggest culprit in exaggerating the potential benefit of new cancer drugs, and that could lead to misunderstandings among patients and the public, according to a new JAMA Oncology report.
The American Society of Clinical Oncology says the CMS should look at episode-based or bundled payment instead of site-neutral payment, as federally proposed.
Cancer is much less common in elephants than in humans, even though the big beasts' bodies have many more cells. That's a paradox known among scientists, and now researchers think they may have an explanation.
Members of the American Society for Clinical Oncology called on legislators Tuesday to build upon the provisions in the 21st Century Cures Act to improve research and treatment.
What particularly struck Design Awards judge Rulon Stacey about the new Memorial Sloan Kettering Cancer Center in West Harrison, N.Y., was the prominent staircase in the middle of the lobby.